[1]Patent:US6133468,2000,A
[1]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-WO2016/4136,2016,A1
[1]Patent:CN109651423,2019,A.Locationinpatent:Paragraph0116-0123
[2]Patent:WO2016/4136,2016,A1.Locationinpatent:Paragraph001041
762292-63-7
33924-45-7
68120-44-5
66192-24-3
75002-98-1
69190-56-3
227598-41-6 | 4-(1,3-Dioxo-1,3-dihydro-isoindol-2-ylmethyl)-benzoic acid | AA00I4EF | MFCD00553451
2425-85-6 | 1-((4-Methyl-2-nitrophenyl)diazenyl)naphthalen-2-ol | AA00I4L9 | MFCD00003910
25617-34-9 | N-(2,2-Dimethylpropanoyl)-4-(trifluoromethyl)aniline | AA00I4T2 | MFCD03094126
268734-29-8 | (3R)-4-(2-chlorophenyl)-3-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}butanoic acid | AA00I506 | MFCD01860899
27848-84-6 | [(2S,4R,7R)-2-methoxy-6,11-dimethyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),9,12,14-tetraen-4-yl]methyl 5-bromopyridine-3-carboxylate | AA00I55P | MFCD00869626
2977-45-9 | 2,2-Dimethyl-1,2,3,4-tetrahydronaphthalen-1-one | AA00I5FK | MFCD22565862
30675-13-9 | TCID | AA00I5OK | MFCD00239209
3150-24-1 | 4-Nitrophenyl-beta-d-galactopyranoside | AA00I5VX | MFCD00150725
325732-21-6 | 3-[(2-chlorophenyl)sulfamoyl]benzoic acid | AA00I63F | MFCD02696649
330628-04-1 | Dmf-dg phosphoramidite | AA00I6AK | MFCD09842106